How CRISPR is Helping in The Battle Against Cancer


CRISPR-Cas9 gene editing, found in nature as a bacterial immune defence mechanism, was first harnessed by scientists as a laboratory tool in 2012 to knock out or mutate genes of interest.(1,2,3) This ground-breaking technique is now commonly used on cell lines to monitor the effects of specific mutations or the function of a specific gene, with … Read moreHow CRISPR is Helping in The Battle Against Cancer

LifeSpan BioSciences, Inc. announces the acquisition of Everest Biotech

Lsbio Blog

Release Date: July 31st, 2019 Seattle, Washington State, USA– June 2019 – LifeSpan BioSciences (LSBio), a leading provider of antibodies and life science research reagents is pleased to announce its acquisition of Everest Biotech. Everest Biotech are ISO 9001:2015 certified experts in antigen affinity purified goat polyclonal antibodies. The acquisition of Everest Biotech further expands … Read moreLifeSpan BioSciences, Inc. announces the acquisition of Everest Biotech

Plastics, Pollution and A New Bacterial Hope for Recycling

Plastic And Petase Copy

There have been growing concerns over the amount of waste plastic is being released into the environment, especially into our oceans. Causing, as yet, untold harm to aquatic life and contamination of the food chain. Tiny plastic particles, known as microplastics, can be ingested by sea life and by this route enter the human food … Read morePlastics, Pollution and A New Bacterial Hope for Recycling

Bio-Helix Exclusive B2B Free Trial Offer!

Bio Helix

PSL Alliance Member Bio-Helix has been in the life sciences research market for 12 years providing top quality, ISO 9001:2008 certified, molecular biology reagents to researchers globally. Bio-Helix brands GeneDirex, PureDirex and now LifeDirex offer a product range that includes DNA markers, protein ladders, nucleic acid purification kits, western blotting solutions, enhanced chemiluminescent (ECL) substrates … Read moreBio-Helix Exclusive B2B Free Trial Offer!

Mergers & Acquisition – The Pivotal Scientific Way


The market in research reagents and diagnostics has been very active in the latter part of 2018 and early 2019 with a large number of transactions undertaken. Most of these appear to have been by private equity expanding their platform approach either in specific product groups or across geographies. Trade sales however remain stable especially … Read moreMergers & Acquisition – The Pivotal Scientific Way

Business Development – Reflecting on Pivotal Links 2019

Pivotal Links 2019

The curtain has closed on Pivotal Links UK for another year, and what a networking event it was. Pivotal Scientific are so grateful and humbled by the outcome, and how far some attendees travel. It really is a wonderful occasion to meet with many fellow PSL Alliance members, Recommended Distributors and also welcome new attendees. … Read moreBusiness Development – Reflecting on Pivotal Links 2019

Antibodies… What Are The Alternatives?

Antibody 76 M

The use of antibodies in basic research is very well established with an estimated research reagent market size of $1.4 billion. The value of the therapeutic antibody market is considerably larger, with antibody-based drugs in clinical use to treat conditions such as cancer, rheumatoid arthritis and Crohn’s disease. The recent growth of the antibody therapeutics … Read moreAntibodies… What Are The Alternatives?

Pivotal Links Testimonial – Vertebrate Antibodies

Pivotal Links 2019

“Vertebrate Antibodies was established in 2011 by four scientists; including myself, Abdo, Steve and Beatriz. In the beginning, we had a very academic focus through collaborations with prominent scientists such as Professors Graeme Murray and Christopher Secombers, promoting and citing Vertebrate Antibodies’ products through international conferences and publications. Jump forward to 2017 and although product … Read morePivotal Links Testimonial – Vertebrate Antibodies

Antibody Validation… Is There Still A Crisis?

3d Illustration Of Antibodies Attacking Virus Cell Into The Bloodstream

Reliable antibodies are essential: whether you are planning to publish a ground-breaking piece of research, or are carrying out routine assays within your laboratory; reproducibility is key. Over the years there has been much debate regarding who should take responsibility for antibody validation. Is it the responsibility of the antibody supplier to offer a fully … Read moreAntibody Validation… Is There Still A Crisis?

Do NOT follow this link or you will be banned from the site!